​Bain Capital rakes in $720M for first life sciences fund

Bain Capital said Tuesday it has raised $720 million for its first fund devoted solely to life science companies, a project led by former Biogen executive Adam Koppel. The fund, called Bain Capital Life Sciences, has already made its presence felt in the local biotech cluster. On March 30, the fund, along with RA Capital Management, led a $50 million Series C round for Solid Biosciences, which is working on gene therapy treatments for Duchenne muscular dystrophy . That same day, Bain’s life science…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news